<- Go Home
Aclarion, Inc.
Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
Market Cap
$1.9M
Volume
1.2M
Cash and Equivalents
$1.3M
EBITDA
-$4.7M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-$34.2K
Profit Margin
69.45%
52 Week High
$7.40
52 Week Low
$0.16
Dividend
N/A
Price / Book Value
0.72
Price / Earnings
-0.17
Price / Tangible Book Value
1.48
Enterprise Value
$515.5K
Enterprise Value / EBITDA
-0.11
Operating Income
-$4.8M
Return on Equity
745.47%
Return on Assets
-127.69
Cash and Short Term Investments
$1.4M
Debt
N/A
Equity
$2.5M
Revenue
$49.3K
Unlevered FCF
-$3.3M
Sector
Health Care Technology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium